Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
that would be nice
Repost
When merger happens and if LCC is at $20 then AAMRQ shareholders will get both cash and new AAG stock equivalent to $9 per AAMRQ share they own. American Airlines Group will be name of the new company and stock symbol AAG.
The break down is as follows:
LCC = AAMRQ
$12 = $.94
$14 = $1.09
$16 = $2.80
$18 = $6.01
$19 = $8.76
$20 = $9.23
LCC ^ .44 @20.57
Agreed, watching LCC slao.
looks like LCC is going to gap ^
LCC up .38 in after hours
agreed, someone knows something, look at size of buys at the ask!
OWW Orbitz Worldwide Raised To Buy From Hold By Benchmark
SVNT Press Release
Source: Savient Pharmaceuticals, Inc.
On Sunday August 2, 2009, 6:00 pm EDT
Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)
http://finance.yahoo.com/news/Savient-Pharmaceuticals-prnews-2370870283.html?x=0&.v=1
Tanker TBI
CIT move up
Gapper ELN
AA - huge blocks AH
Insmed Announces Results of IPLEX(TM) Phase II Trial in Myotonic Muscular Dystrophy
The results of the trial indicated that IPLEX(TM) did not exhibit a statistically significant improvement in the functional measure of endurance by the six-minute walk test, muscle function, muscle strength, or quality of life in any of the tests utilized in this study. Based on the limited number of subjects enrolled with significant impairments in cognitive function, gastrointestinal function or pain, Insmed was unable to reach any conclusions regarding the effects of IPLEX(TM) on these endpoints
http://finance.yahoo.com/news/Insmed-Announces-Results-of-prnews-21832337.html?x=0&.v=1
ETFC E*TRADE FBR Capital Underperform » Outperform $2
Smith & Wesson Raised To Outperform From Mkt Perform By Northland Securities >SWHCLast update: 6/19/2009 11:46:11 AM
think it will run some into the close?
CVS Unit Played Both Sides, Lilly Zyprexa Lawsuit Files Show
http://www.bloomberg.com/apps/news?pid=20601127&sid=aiewKdPT_wOQ
Eli Lilly’s Zyprexa Articles Ghostwritten by Company Officials
http://visitbulgaria.info/10313-eli-lilly%E2%80%99s-zyprexa-articles-ghostwritten-company-officials
Gapper MRVL
due for a pull back IMO, volumn decreasing, down AH from close. will probably pop some in the morning, I'll short near 2.85 if it looks weak
all in my opinion
06/04/2009 17:04 *DJ Bank Of America Director Tillman Resigns >BAC
RAD - see if it can get through that 1.63 wall this time
Rite Aid Raised To Outperform From Underperform By Raymond James >RAD
RAD - good size blocks on the ask
CTIC : A dramatic mid-day stock halt and a deftly worded press release can't disguise the fact that Cell Therapeutics'(CTIC Quote) chemotherapy drug pixantrone is causing significant heart toxicity.
http://www.thestreet.com/_yahoo/story/10507889/1/cell-therapeutics-downplays-drugs-heart-risks.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA
KERX is got a rehash new out again today. There is also the possibilty of a partner news today from the Scuttlebutt on IHUB. AEZS is the candidate.
posted by aliangel
Tanker VNDA
Gapper UEC
KERX - watching got a few @ 19:59:52 05/27/09
must be halted
I bought this 2 years ago as a lotto play for $5 the day it was halted, I sold @ $18.75, went to $23.
brikk, did you see this?
do I win the FAZ contest?
will watch
Verenium Cut To Hold From Buy By Jefferies - Briefing.com >VRNMLast update: 4/6/2009
protectionism - it begins